CBX3 and cervical cancer: Moreover, the additional analysis results in the ONCOMINE database (Fig. 1c) further confirmed that CBX3 is highly expressed in breast cancer, cervical cancer, lung cancer, kidney cancer, colorectal cancer, and ovarian (P < 0.01), compared with normal controls.